{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:41:31Z","timestamp":1684471291576},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,11,28]],"date-time":"2012-11-28T00:00:00Z","timestamp":1354060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1038\/ejhg.2012.264","type":"journal-article","created":{"date-parts":[[2012,11,28]],"date-time":"2012-11-28T11:23:07Z","timestamp":1354101787000},"page":"701-702","source":"Crossref","is-referenced-by-count":0,"title":["Can manipulation of splicing offer gene therapy possibilities to those with tumour-prone disorders?"],"prefix":"10.1038","volume":"21","author":[{"given":"D Gareth R","family":"Evans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,28]]},"reference":[{"issue":"7","key":"BFejhg2012264_CR1","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/ejhg.2012.261","volume":"21","author":"Elisabeth Castellanos","year":"2012","unstructured":"Castellanos E, Rosas I, Solanes A et al: In vitro antisense therapeutics for a deep intronic mutation causing neurofibromatosis type 2. E J Hum Gen 2013, (e-pub ahead of print; doi:10.1038\/ejhg.2012.261).","journal-title":"European Journal of Human Genetics"},{"key":"BFejhg2012264_CR2","doi-asserted-by":"publisher","first-page":"e33576","DOI":"10.1371\/journal.pone.0033576","volume":"7","author":"LA Owen","year":"2012","unstructured":"Owen LA, Uehara H, Cahoon J, Huang W, Simonis J, Ambati BK : Morpholino-mediated increase in soluble Flt-1 expression results in decreased ocular and tumor neovascularization. PLoS One 2012; 7: e33576.","journal-title":"PLoS One"},{"key":"BFejhg2012264_CR3","doi-asserted-by":"crossref","unstructured":"Anthony K, Feng L, Arechavala-Gomeza V et al: Exon skipping quantification by qRT-PCR in Duchenne muscular dystrophy patients treated with the antisense oligomer eteplirsen. Hum Gene Ther Methods 2012, (e-pub ahead of print).","DOI":"10.1089\/hgtb.2012.117"},{"key":"BFejhg2012264_CR4","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa1011367","volume":"364","author":"NM Goemans","year":"2011","unstructured":"Goemans NM, Tulinius M, van den Akker JT et al: Systemic administration of PRO051 in Duchenne's muscular dystrophy. N Engl J Med 2011; 364: 1513\u20131522.","journal-title":"N Engl J Med"},{"key":"BFejhg2012264_CR5","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1089\/hum.2012.140","volume":"23","author":"BJ Byrne","year":"2012","unstructured":"Byrne BJ, Falk DJ, Cl\u00e9ment N, Mah CS : Gene therapy approaches for lysosomal storage disease: next-generation treatment. Hum Gene Ther 2012; 23: 808\u2013815.","journal-title":"Hum Gene Ther"},{"key":"BFejhg2012264_CR6","first-page":"CD005599","volume":"10","author":"TW Lee","year":"2012","unstructured":"Lee TW, Southern KW : Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease. Cochrane Database Syst Rev 2012; 10: CD005599.","journal-title":"Cochrane Database Syst Rev"},{"key":"BFejhg2012264_CR7","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/jmedgenet-2011-100562","volume":"49","author":"A Wilding","year":"2012","unstructured":"Wilding A, Ingham SL, Lalloo F et al: Life expectancy in hereditary cancer predisposing diseases: an observational study. J Med Genet 2012; 49: 264\u2013269.","journal-title":"J Med Genet"},{"issue":"10 Supplement","key":"BFejhg2012264_CR8","first-page":"S103","volume":"49","author":"E Sach","year":"2012","unstructured":"Sach E, Howard E, Wallace A et al: Three years experience of offering a neurofibromatosis type 1 (NF1) mutation testing service centred on cDNA analysis. J Med Genet 2012; 49 (10 Supplement): S103.","journal-title":"J Med Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg2012264.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2012264","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2012264.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:07:01Z","timestamp":1684429621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg2012264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,28]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["BFejhg2012264"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2012.264","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,28]]}}}